<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Open Forum Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Open Forum Infect Dis</journal-id><journal-id journal-id-type="publisher-id">ofid</journal-id><journal-title-group><journal-title>Open Forum Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2328-8957</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">6255339</article-id><article-id pub-id-type="doi">10.1093/ofid/ofy210.934</article-id><article-id pub-id-type="publisher-id">ofy210.934</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>B. Poster Abstracts</subject></subj-group></subj-group></article-categories><title-group><article-title>1099. Antibiotic Prescriptions for Acute Gastroenteritis during Office and Emergency Department Visits&#x02013;United States, 2006&#x02013;2015</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Collins</surname><given-names>Jennifer P</given-names></name><degrees>MD, MSc</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Watkins</surname><given-names>Louise Francois</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>King</surname><given-names>Laura M</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Bartoces</surname><given-names>Monina</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="AF0003">3</xref></contrib><contrib contrib-type="author"><name><surname>Fleming-Dutra</surname><given-names>Katherine</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0004">4</xref></contrib><contrib contrib-type="author"><name><surname>Friedman</surname><given-names>Cindy</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="AF0001">1</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0002"><label>2</label>Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0003"><label>3</label>Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia</aff><aff id="AF0004"><label>4</label>CDC, Atlanta, Georgia</aff><pub-date pub-type="collection"><month>11</month><year>2018</year></pub-date><pub-date pub-type="epub" iso-8601-date="2018-11-26"><day>26</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>11</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>5</volume><issue>Suppl 1</issue><issue-title>ID Week 2018 Abstracts</issue-title><fpage>S330</fpage><lpage>S330</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2018</copyright-year><license license-type="cc-by-nc-nd" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xlink:href="ofy210.934.pdf"/><abstract><title>Abstract</title><sec id="s1"><title>Background</title><p>Acute gastroenteritis (AGE) is a major cause of office and emergency department (ED) visits in the United States. Most patients can be managed with supportive care alone, although some require antibiotics. Limiting unnecessary antibiotic use can minimize side effects and the development of resistance. We used national data to assess antibiotic prescribing for AGE to target areas for stewardship efforts.</p></sec><sec id="s2"><title>Methods</title><p>We used the 2006&#x02013;2015 National Hospital Ambulatory Medical Care Survey of EDs and National Ambulatory Medical Care Survey to describe antibiotic prescribing for AGE. An AGE visit was defined as one with a new problem (&#x0003c;3 months) as the main visit indication and an ICD-9 code for bacterial or viral gastrointestinal infection or AGE symptoms (nausea, vomiting, and/or diarrhea). We excluded visits with ICD-9 codes for <italic>Clostridium difficile</italic> or an infection usually requiring antibiotics (e.g., pneumonia). We calculated national annual percentage estimates based on weights of sampled visits and used an &#x003b1; level of 0.01, recommended for these data.</p></sec><sec id="s3"><title>Results</title><p>Of the 12,191 sampled AGE visits, 13% (99% CI: 11&#x02013;15%) resulted in antibiotic prescriptions, equating to an estimated 1.3 million AGE visits with antibiotic prescriptions annually. Antibiotics were more likely to be prescribed in office AGE visits (16%, 99% CI: 12&#x02013;20%) compared with ED AGE visits (11%, 99% CI: 9&#x02013;12%; <italic>P &#x0003c;</italic> 0.01). Among AGE visits with antibiotic prescriptions, the most frequently prescribed were fluoroquinolones (29%, 99% CI: 21&#x02013;36%), metronidazole (18%, 99% CI: 13&#x02013;24%), and penicillins (18%, 99% CI: 11&#x02013;24%). Antibiotics were prescribed for 25% (99% CI: 8&#x02013;42%) of visits for bacterial AGE, 16% (99% CI: 12&#x02013;21%) for diarrhea without nausea or vomiting, and 11% (99% CI: 8&#x02013;15%) for nausea, vomiting, or both without diarrhea. Among AGE visits with fever (T &#x02265; 100.9<sup>o</sup>F) at the visit, 21% (99% CI: 11&#x02013;31%) resulted in antibiotic prescriptions.</p></sec><sec id="s4"><title>Conclusion</title><p>Patients treated for AGE in office settings were significantly more likely to receive prescriptions for antibiotics compared with those seen in an ED, despite likely lower acuity. Antibiotic prescribing was also high for visits for nausea or vomiting, conditions that usually do not require antibiotics. Antimicrobial stewardship for AGE is needed, especially in office settings.</p></sec><sec id="s5"><title>Disclosures</title><p>
<bold>All authors:</bold> No reported disclosures.</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front><back><notes id="n1"><p>
<bold>Session:</bold> 133. Enteric Infections</p><p>
<italic>Friday, October 5, 2018: 12:30 PM</italic>
</p></notes></back></article>